The dynamics of the mitochondrial organelle as a potential therapeutic target

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 1, 2013, Pages 22-32

  Anne Stetler, R ^a,b,c   Leak, Rehana K ^d   Gao, Yanqin ^a   Chen, Jun ^a,b,c  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d DUQUESNE UNIVERSITY   (United States)

Author keywords

Biogenesis; cerebral ischemia; mitochondrial dynamics; mitophagy; neurodegeneration

Indexed keywords

CARDIOLIPIN; COPPER ZINC SUPEROXIDE DISMUTASE; HUNTINGTIN; PARKIN;

AMYOTROPHIC LATERAL SCLEROSIS; AUTOPHAGY; BIOGENESIS; BRAIN ISCHEMIA; CELL ORGANELLE; HEREDITARY MOTOR SENSORY NEUROPATHY; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL MEMBRANE; MITOPHAGY; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN SYNTHESIS; REVIEW;

ANIMALS; BRAIN ISCHEMIA; HUMANS; MEMBRANE FUSION; MITOCHONDRIA; MITOCHONDRIAL DEGRADATION; MITOCHONDRIAL MEMBRANES; MITOCHONDRIAL PROTEINS; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS;

EID: 84871921370     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2012.158     Document Type: Review

References (124)

1. Goldenthal MJ, Marin-Garcia J. Mitochondrial signaling pathways: a receiver/integrator organelle. Mol Cell Biochem 2004; 262: 1-16. (Pubitemid 39158049)
2. Kanamaru Y, Sekine S, Ichijo H, Takeda K. The phosphorylation-dependent regulationof mitochondrial proteins in stress responses. J Signal Transduct 2012;2012: 931215.
3. Akepati VR, Muller EC, Otto A, Strauss HM, Portwich M, Alexander C. Characterizationof OPA1 isoforms isolated from mouse tissues. J Neurochem 2008;106: 372-383. (Pubitemid 351840223)
4. Dennis EA, Kennedy EP. Intracellular sites of lipid synthesis and the biogenesis ofmitochondria. J Lipid Res 1972; 13: 263-267.
5. Michel S, Wanet A, De Pauw A, Rommelaere G, Arnould T, Renard P. Crosstalkbetween mitochondrial (dys)function and mitochondrial abundance. J CellPhysiol 2012; 227: 2297-2310.
6. Medeiros DM. Assessing mitochondria biogenesis. Methods 2008; 46: 288-294.
7. Falkenberg M, Larsson NG, Gustafsson CM. DNA replication and transcription inmammalian mitochondria. Annu Rev Biochem 2007; 76: 679-699.
8. Mendelev N, Mehta SL, Witherspoon S, He Q, Sexton JZ, Li PA. Upregulation ofhuman selenoprotein H in murine hippocampal neuronal cells promotes mitochondrialbiogenesis and functional performance. Mitochondrion 2011; 11: 76-82.
9. Hock MB, Kralli A. Transcriptional control of mitochondrial biogenesis andfunction. Annu Rev Physiol 2009; 71: 177-203.
10. Piantadosi CA, Carraway MS, Babiker A, Suliman HB. Heme oxygenase-1 regulatescardiac mitochondrial biogenesis via Nrf2-mediated transcriptional controlof nuclear respiratory factor-1. Circ Res 2008; 103: 1232-1240.
11. Suliman HB, Sweeney TE, Withers CM, Piantadosi CA. Co-regulation of nuclearrespiratory factor-1 by NFkappaB and CREB links LPS-induced inflammation tomitochondrial biogenesis. J Cell Sci 2010; 123(Pt 15): 2565-2575.
12. Miller BF, Hamilton KL. A perspective on the determination of mitochondrialbiogenesis. Am J Physiol Endocrinol Metab 2012; 302: E496-E499.
13. Voos W, Rottgers K. Molecular chaperones as essential mediators of mitochondrialbiogenesis. Biochim Biophys Acta 2002; 1592: 51-62. (Pubitemid 35015165)
14. Hood DA, Adhihetty PJ, Colavecchia M, Gordon JW, Irrcher I, Joseph AM et al.Mitochondrial biogenesis and the role of the protein import pathway. Med SciSports Exerc 2003; 35: 86-94. (Pubitemid 36084146)
15. Rapaport D. Biogenesis of the mitochondrial TOM complex. Trends Biochem Sci2002; 27: 191-197. (Pubitemid 34270767)
16. Gesing A, Masternak MM, Wang F, Joseph AM, Leeuwenburgh C, Westbrook R et al.Expression of key regulators of mitochondrial biogenesis in growth hormonereceptor knockout (GHRKO) mice is enhanced but is not further improved byother potential life-extending interventions. J Gerontol A Biol Sci Med Sci 2011; 66:1062-1076.
17. Chicco AJ, Sparagna GC. Role of cardiolipin alterations in mitochondrial dysfunctionand disease. Am J Physiol Cell Physiol 2007; 292: C33-C44. (Pubitemid 46115119)
18. Gohil VM, Gvozdenovic-Jeremic J, Schlame M, Greenberg ML. Binding of 10-Nnonylacridine orange to cardiolipin-deficient yeast cells: implications for assayof cardiolipin. Anal Biochem 2005; 343: 350-352. (Pubitemid 41074053)
19. Kutik S, Rissler M, Guan XL, Guiard B, Shui G, Gebert N et al. The translocatormaintenance protein Tam41 is required for mitochondrial cardiolipin biosynthesis.J Cell Biol 2008; 183: 1213-1221.
20. Gohil VM, Greenberg ML. Mitochondrial membrane biogenesis: phospholipidsand proteins go hand in hand. J Cell Biol 2009; 184: 469-472.
21. Song W, Bossy B, Martin OJ, Hicks A, Lubitz S, Knott AB et al. Assessing mitochondrialmorphology and dynamics using fluorescence wide-field microscopyand 3D image processing. Methods 2008; 46: 295-303.
22. Beeson CC, Beeson GC, Schnellmann RG. A high-throughput respirometric assayfor mitochondrial biogenesis and toxicity. Anal Biochem 2010; 404: 75-81.
23. Ashrafi G, Schwarz TL. The pathways of mitophagy for quality control andclearance of mitochondria. Cell Death Differ 2012; PMID: 22743996.
24. Novak I. Mitophagy: a complex mechanism of mitochondrial removal. AntioxidRedox Signal 2012; 17: 794-802.
25. Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G et al. Fission andselective fusion govern mitochondrial segregation and elimination by autophagy.EMBO J 2008; 27: 433-446. (Pubitemid 351161653)
26. Hyde BB, Twig G, Shirihai OS. Organellar vs cellular control of mitochondrialdynamics. Semin Cell Dev Biol 2010; 21: 575-581.
27. Schweers RL, Zhang J, Randall MS, Loyd MR, Li W, Dorsey FC et al. NIX is requiredfor programmed mitochondrial clearance during reticulocyte maturation. ProcNatl Acad Sci USA 2007; 104: 19500-19505.
28. Sandoval H, Thiagarajan P, Dasgupta SK, Schumacher A, Prchal JT, Chen M et al.Essential role for Nix in autophagic maturation of erythroid cells. Nature 2008;454: 232-235. (Pubitemid 351969889)
29. Zhang J, Ney PA. Reticulocyte mitophagy: monitoring mitochondrial clearance ina mammalian model. Autophagy 2010; 6: 405-408.
30. Priault M, Salin B, Schaeffer J, Vallette FM, di Rago JP, Martinou JC. Impairing thebioenergetic status and the biogenesis of mitochondria triggers mitophagy inyeast. Cell Death Differ 2005; 12: 1613-1621. (Pubitemid 41679166)
31. Kim I, Lemasters JJ. Mitophagy selectively degrades individual damaged mitochondriaafter photoirradiation. Antioxid Redox Signal 2011; 14: 1919-1928.
32. Narendra D, Tanaka A, Suen DF, Youle RJ. Parkin is recruited selectively to impairedmitochondria and promotes their autophagy. J Cell Biol 2008; 183: 795-803.
33. Lemasters JJ. Selective mitochondrial autophagy, or mitophagy, as a targeteddefense against oxidative stress, mitochondrial dysfunction, and aging. RejuvenationRes 2005; 8: 3-5.
34. Deas E, Wood NW, H Plun-Favreau. Mitophagy and Parkinson's disease: thePINK1-parkin link. Biochim Biophys Acta 2011; 1813: 623-633.
35. Kissova I, Deffieu M, Manon S, Camougrand N. Uth1p is involved in the autophagicdegradation of mitochondria. J Biol Chem 2004; 279: 39068-39074.
36. Jin SM, Youle RJ. PINK1-and Parkin-mediated mitophagy at a glance. J Cell Sci2012; 125(Pt 4): 795-799.
37. Jin SM, Lazarou M, Wang C, Kane LA, Narendra DP, Youle RJ. Mitochondrialmembrane potential regulates PINK1 import and proteolytic destabilization byPARL. J Cell Biol 2010; 191: 933-942.
38. Meissner C, Lorenz H, Weihofen A, Selkoe DJ, Lemberg MK. The mitochondrialintramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking.J Neurochem 2011; 117: 856-867.
39. Novak I, Kirkin V, McEwan DG, Zhang J, Wild P, Rozenknop A et al. Nix is a selectiveautophagy receptor for mitochondrial clearance. EMBO Rep 2010; 11: 45-51.
40. Zhang J, Ney PA. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy.Cell Death Differ 2009; 16: 939-946.
41. Zhu J, Dagda RK, Chu CT. Monitoring mitophagy in neuronal cell cultures.Methods Mol Biol 2011; 793: 325-339.
42. Huang C, Andres AM, Ratliff EP, Hernandez G, Lee P, Gottlieb RA. Preconditioninginvolves selective mitophagy mediated by Parkin and p62/SQSTM1. PLoS One2011; 6: e20975.
43. May AI, Devenish RJ, Prescott M. The many faces of mitochondrial autophagy:making sense of contrasting observations in recent research. Int J Cell Biol 2012;2012: 431684.
44. Mijaljica D, Prescott M, Devenish RJ. A fluorescence microscopy assay formonitoring mitophagy in the yeast Saccharomyces cerevisiae. J Vis Exp 2011;PMID: 21788936.
45. Miller KE, Sheetz MP. Axonal mitochondrial transport and potential are correlated.J Cell Sci 2004; 117(Pt 13): 2791-2804. (Pubitemid 38997261)
46. Baqri RM, Turner BA, Rheuben MB, Hammond BD, Kaguni LS, Miller KE. Disruptionof mitochondrial DNA replication in Drosophila increases mitochondrial fastaxonal transport in vivo. PLoS One 2009; 4: e7874.
47. Chang DT, Honick AS, Reynolds IJ. Mitochondrial trafficking to synapses in culturedprimary cortical neurons. J Neurosci 2006; 26: 7035-7045. (Pubitemid 44309871)
48. Verburg J, Hollenbeck PJ. Mitochondrial membrane potential in axons increases withlocal nerve growth factor or semaphorin signaling. J Neurosci 2008; 28: 8306-8315.
49. Hollenbeck PJ, Saxton WM. The axonal transport of mitochondria. J Cell Sci 2005;118(Pt 23): 5411-5419. (Pubitemid 43079283)
50. Palmer CS, Osellame LD, Stojanovski D, Ryan MT. The regulation of mitochondrialmorphology: intricate mechanisms and dynamic machinery. Cell Signal2011; 23: 1534-1545.
51. Choi SY, Huang P, Jenkins GM, Chan DC, Schiller J, Frohman MA. A common lipidlinks Mfn-mediated mitochondrial fusion and SNARE-regulated exocytosis. NatCell Biol 2006; 8: 1255-1262. (Pubitemid 44660590)
52. Song Z, Ghochani M, McCaffery JM, Frey TG, Chan DC. Mitofusins and OPA1mediate sequential steps in mitochondrial membrane fusion. Mol Biol Cell 2009;20: 3525-3532.
53. Grohm J, Plesnila N, Culmsee C. Bid mediates fission, membrane permeabilizationand peri-nuclear accumulation of mitochondria as a prerequisite for oxidativeneuronal cell death. Brain Behav Immun 2010; 24: 831-838.
54. Sheridan C, Delivani P, Cullen SP, Martin SJ. Bax-or Bak-induced mitochondrialfission can be uncoupled from cytochrome C release. Mol Cell 2008; 31: 570-585.
55. Llambi F, Moldoveanu T, Tait SW, Bouchier-Hayes L, Temirov J, McCormick LL etal. A unified model of mammalian BCL-2 protein family interactions at themitochondria. Mol Cell 2011; 44: 517-531.
56. Ryu SW, Choi K, Yoon J, Kim S, Choi C. Endoplasmic reticulum-specific BH3-onlyprotein BNIP1 induces mitochondrial fragmentation in a Bcl-2-and Drp1-dependent manner. J Cell Physiol 2012; 227: 3027-3035.
57. Arnold B, Cassady SJ, VanLaar VS, Berman SB. Integrating multiple aspects ofmitochondrial dynamics in neurons: age-related differences and dynamicchanges in a chronic rotenone model. Neurobiol Dis 2011; 41: 189-200.
58. Kageyama Y, Zhang Z, Roda R, Fukaya M, Wakabayashi J, Wakabayashi N et al.Mitochondrial division ensures the survival of postmitotic neurons by suppressingoxidative damage. J Cell Biol 2012; 197: 535-551.
59. Osman C, Voelker DR, Langer T. Making heads or tails of phospholipids inmitochondria. J Cell Biol 2011; 192: 7-16.
60. Zheng M, Kim SK, Joe Y, Back SH, Cho HR, Kim HP et al. Sensing endoplasmicreticulum stress by protein kinase RNA-like endoplasmic reticulum kinase promotesadaptive mitochondrial DNA biogenesis and cell survival via heme oxygenase-1/carbon monoxide activity. FASEB J 2012; 26: 2558-2568.
61. Garedew A, Andreassi C, Moncada S. Mitochondrial dynamics, biogenesis, andfunction are coordinated with the cell cycle by APC/C CDH1. Cell Metab 2012; 15:466-479.
62. Piantadosi CA, Suliman HB. Transcriptional control of mitochondrial biogenesisand its interface with inflammatory processes. Biochim Biophys Acta 2012; 1820:532-541.
63. Zhang F, Wang S, Gan L, Vosler PS, Gao Y, Zigmond MJ et al. Protectiveeffects and mechanisms of sirtuins in the nervous system. Prog Neurobiol 2011;95: 373-395.
64. Webster BR, Lu Z, Sack MN, Scott I. The role of sirtuins in modulating redoxstressors. Free Radic Biol Med 2012; 52: 281-290.
65. Nemoto S, Fergusson MM, Finkel T. SIRT1 functionally interacts with the metabolicregulator and transcriptional coactivator PGC-1{alpha}. J Biol Chem 2005;280: 16456-16460. (Pubitemid 40616776)
66. Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmentalstresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 2007; 47:89-116.
67. Piantadosi CA, Withers CM, Bartz RR, MacGarvey NC, Fu P, Sweeney TE et al.Heme oxygenase-1 couples activation of mitochondrial biogenesis to antiinflammatorycytokine expression. J Biol Chem 2011; 286: 16374-16385.
68. Song Z, Chen H, Fiket M, Alexander C, Chan DC. OPA1 processing controlsmitochondrial fusion and is regulated by mRNA splicing, membrane potential,and Yme1L. J Cell Biol 2007; 178: 749-755. (Pubitemid 47347360)
69. Chang CR, Blackstone C. Dynamic regulation of mitochondrial fission throughmodification of the dynamin-related protein Drp1. Ann NY Acad Sci 2010; 1201:34-39.
70. Zuchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali EL etal. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004; 36: 449-451. (Pubitemid 38620027)
71. Feely SM, Laura M, Siskind CE, Sottile S, Davis M, Gibbons VS et al. MFN2mutations cause severe phenotypes in most patients with CMT2A. Neurology2011; 76: 1690-1696.
72. Pedrola L, Espert A, Wu X, Claramunt R, Shy ME, Palau F. GDAP1, the proteincausing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and isassociated with mitochondria. Hum Mol Genet 2005; 14: 1087-1094. (Pubitemid 40575884)
73. Niemann A, Ruegg M, La Padula V, Schenone A, Suter U. Ganglioside-induceddifferentiation associated protein 1 is a regulator of the mitochondrial network:new implications for Charcot-Marie-Tooth disease. J Cell Biol 2005; 170: 1067-1078. (Pubitemid 41362639)
74. Sole G, Ferrer X, Vital C, Martin-Negrier ML, Vital A, Latour P. Ultrastructuralmitochondrial modifications characteristic of mitofusin 2 mutations (CMT2A).J Peripher Nerv Syst 2009; 14: 206-207.
75. Rosenstock TR, Duarte AI, Rego AC. Mitochondrial-associated metabolic changesand neurodegeneration in Huntington's disease-from clinical features to thebench. Curr Drug Targets 2010; 11: 1218-1236.
76. Wang H, Lim PJ, Karbowski M, Monteiro MJ. Effects of overexpression of huntingtinproteins on mitochondrial integrity. Hum Mol Genet 2009; 18: 737-752.
77. Orr AL, Li S, Wang CE, Li H, Wang J, Rong J et al. N-terminal mutant huntingtinassociates with mitochondria and impairs mitochondrial trafficking. J Neurosci2008; 28: 2783-2792. (Pubitemid 351398886)
78. Song W, Chen J, Petrilli A, Liot G, Klinglmayr E, Zhou Y et al. Mutant huntingtinbinds the mitochondrial fission GTPase dynamin-related protein-1 and increasesits enzymatic activity. Nat Med 2011; 17: 377-382.
79. Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, Krainc D. Transcriptionalrepression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunctionand neurodegeneration. Cell 2006; 127: 59-69. (Pubitemid 44466642)
80. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S et al.Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.Nature 1998; 392: 605-608. (Pubitemid 28207717)
81. Mata IF, Lockhart PJ, Farrer MJ. Parkin genetics: one model for Parkinson's disease.Hum Mol Genet 2004; 13 Spec No 1: R127-R133. (Pubitemid 38443806)
82. Hampe C, Ardila-Osorio H, Fournier M, Brice A, Corti O. Biochemical analysis ofParkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligasewith monoubiquitylation capacity. Hum Mol Genet 2006; 15: 2059-2075. (Pubitemid 43923396)
83. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S et al.Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science2004; 304: 1158-1160. (Pubitemid 38661852)
84. Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M et al. Cloningof the gene containing mutations that cause PARK8-linked Parkinson's disease.Neuron 2004; 44: 595-600. (Pubitemid 39531224)
85. Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S et al. Mutations inLRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.Neuron 2004; 44: 601-607. (Pubitemid 39531225)
86. West AB, Moore DJ, Biskup S, Bugayenko A, Smith WW, Ross CA et al. Parkinson'sdisease-associated mutations in leucine-rich repeat kinase 2 augment kinaseactivity. Proc Natl Acad Sci USA 2005; 102: 16842-16847. (Pubitemid 41688864)
87. Wang X, Yan MH, Fujioka H, Liu J, Wilson-Delfosse A, Chen SG et al. LRRK2regulates mitochondrial dynamics and function through direct interaction withDLP1. Hum Mol Genet 2012; 21: 1931-1944.
88. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E et al.Mutations in the DJ-1 gene associated with autosomal recessive early-onsetparkinsonism. Science 2003; 299: 256-259. (Pubitemid 36131051)
89. Wang X, Petrie TG, Liu Y, Liu J, Fujioka H, Zhu X. Parkinson's disease-associatedDJ-1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction.J Neurochem 2012; 121: 830-839.
90. Krebiehl G, Ruckerbauer S, Burbulla LF, Kieper N, Maurer B, Waak J et al. Reducedbasal autophagy and impaired mitochondrial dynamics due to loss of Parkinson'sdisease-associated protein DJ-1. PLoS One 2010; 5: e9367.
91. Song W, Song Y, Kincaid B, Bossy B, Bossy-Wetzel E. Mutant SOD1(G93A) triggersmitochondrial fragmentation in spinal cord motor neurons: Neuroprotection bySIRT3 and PGC-1alpha. Neurobiol Dis 2012; PMID: 22819776.
92. Magrane J, Hervias I, Henning MS, Damiano M, Kawamata H, Manfredi G. MutantSOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamicsabnormalities. Hum Mol Genet 2009; 18: 4552-4564.
93. Magrane J, Sahawneh MA, Przedborski S, Estevez AG, Manfredi G. Mitochondrialdynamics and bioenergetic dysfunction is associated with synaptic alterations inmutant SOD1 motor neurons. J Neurosci 2012; 32: 229-242.
94. Yin W, Signore AP, Iwai M, Cao G, Gao Y, Chen J. Rapidly increased neuronalmitochondrial biogenesis after hypoxic-ischemic brain injury. Stroke 2008; 39:3057-3063.
95. Hokari M, Kuroda S, Kinugawa S, Ide T, Tsutsui H, Iwasaki Y. Overexpression ofmitochondrial transcription factor A (TFAM) ameliorates delayed neuronal deathdue to transient forebrain ischemia in mice. Neuropathology 2010; 30: 401-407.
96. Mengesdorf T, Jensen PH, Mies G, Aufenberg C, Paschen W. Down-regulation ofparkin protein in transient focal cerebral ischemia: A link between stroke anddegenerative disease? Proc Natl Acad Sci USA 2002; 99: 15042-15047. (Pubitemid 35334606)
97. Bertoni-Freddari C, Fattoretti P, Casoli T, Di Stefano G, Solazzi M, Perna E et al.Reactive structural dynamics of synaptic mitochondria in ischemic delayedneuronal death. Ann NY Acad Sci 2006; 1090: 26-34. (Pubitemid 47092105)
98. Liu W, Tian F, Kurata T, Morimoto N, Abe K. Dynamic changes of mitochondrialfusion and fission proteins after transient cerebral ischemia in mice. J NeurosciRes 2012; 90: 1183-1189.
99. Liu W, Tian F, Kurata T, Morimoto N, Abe K. Dynamic changes of mitochondrialfission proteins after transient cerebral ischemia in mice. Brain Res 2012; 1456:94-99.
100. Grohm J, Kim SW, Mamrak U, Tobaben S, Cassidy-Stone A, Nunnari J et al.Inhibition of Drp1 provides neuroprotection in vitro and in vivo. Cell Death Differ2012; 19: 1446-1458.
101. Girbovan C, Morin L, Plamondon H. Repeated resveratrol administrationconfers lasting protection against neuronal damage but induces dose-relatedalterations of behavioral impairments after global ischemia. Behav Pharmacol2012; 23: 1-13.
102. Della-Morte D, Dave KR, DeFazio RA, Bao YC, Raval AP, Perez-Pinzon MA.Resveratrol pretreatment protects rat brain from cerebral ischemic damage via asirtuin 1-uncoupling protein 2 pathway. Neuroscience 2009; 159: 993-1002.
103. Raval AP, Dave KR, Perez-Pinzon MA. Resveratrol mimics ischemicpreconditioning in the brain. J Cereb Blood Flow Metab 2006; 26: 1141-1147.
104. Price NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, North BJ et al. SIRT1is required for AMPK activation and the beneficial effects of resveratrol onmitochondrial function. Cell Metab 2012; 15: 675-690.
105. Steiner JL, Murphy EA, McClellan JL, Carmichael MD, Davis JM. Exercisetraining increases mitochondrial biogenesis in the brain. J Appl Physiol 2011;111: 1066-1071.
106. Patki G, Lau YS. Impact of exercise on mitochondrial transcription factorexpression and damage in the striatum of a chronic mouse model of Parkinson'sdisease. Neurosci Lett 2011; 505: 268-272.
107. Zhang Q, Wu Y, Zhang P, Sha H, Jia J, Hu Y et al. Exercise induces mitochondrialbiogenesis after brain ischemia in rats. Neuroscience 2012; 205: 10-17.
108. Zhang W, Li P, Hu X, Zhang F, Chen J, Gao Y. Omega-3 polyunsaturatedfatty acids in the brain: metabolism and neuroprotection. Front Biosci 2011; 16:2653-2670.
109. Zhang W, Hu X, Yang W, Gao Y, Chen J. Omega-3 polyunsaturated fattyacid supplementation confers long-term neuroprotection against neonatalhypoxic- ischemic brain injury through anti-inflammatory actions. Stroke 2010;41: 2341-2347.
110. Belayev L, Khoutorova L, Atkins KD, Bazan NG. Robust docosahexaenoic acidmediatedneuroprotection in a rat model of transient, focal cerebral ischemia.Stroke 2009; 40: 3121-3126.
111. Flachs P, Horakova O, Brauner P, Rossmeisl M, Pecina P, Franssen-van Hal N et al.Polyunsaturated fatty acids of marine origin upregulate mitochondrialbiogenesis and induce beta-oxidation in white fat. Diabetologia 2005; 48:2365-2375. (Pubitemid 41618929)
112. Liang J, Wang J, Saad Y, Warble L, Becerra E, Kolattukudy PE. Participation ofMCP-induced protein 1 in lipopolysaccharide preconditioning- induced ischemicstroke tolerance by regulating the expression of proinflammatory cytokines.J Neuroinflammation 2011; 8: 182.
113. Zimmermann C, Ginis I, Furuya K, Klimanis D, Ruetzler C, Spatz M et al.Lipopolysaccharide-induced ischemic tolerance is associated with increasedlevels of ceramide in brain and in plasma. Brain Res 2001; 895: 59-65. (Pubitemid 32231138)
114. Stetler RA, Leak RK, Yin W, Zhang L, Wang S, Gao Y et al. Mitochondrialbiogenesis contributes to ischemic neuroprotection afforded by LPSpreconditioning. J Neurochem 2012; 123(Suppl 2): 125-137.
115. Delille HK, Dodt G, Schrader M. Pex11pbeta-mediated maturation of peroxisomes.Commun Integr Biol 2011; 4: 51-54.
116. Kobayashi S, Tanaka A, Fujiki Y. Fis1 DLP1, and Pex11p coordinately regulateperoxisome morphogenesis. Exp Cell Res 2007; 313: 1675-1686. (Pubitemid 46589443)
117. Ribeiro D, Castro I, Fahimi HD, Schrader M. Peroxisome morphology in pathology.Histol Histopathol 2012; 27: 661-676.
118. Twig G, Graf SA, Wikstrom JD, Mohamed H, Haigh SE, Elorza A et al. Tagging andtracking individual networks within a complex mitochondrial web with photoactivatableGFP. Am J Physiol Cell Physiol 2006; 291: C176-C184.
119. Molina AJ, Shirihai OS. Monitoring mitochondrial dynamics with photoactivatable[corrected] green fluorescent protein. Methods Enzymol 2009; 457:289-304.
120. Lovy A, Molina AJ, Cerqueira FM, Trudeau K, Shirihai OS. A faster, high resolution,mtPA-GFP-based mitochondrial fusion assay acquiring kinetic data of multiplecells in parallel using confocal microscopy. J Vis Exp 2012; e3991.
121. Wang Y, Pan Y, Price A, Martin LJ. Generation and characterization of transgenicmice expressing mitochondrial targeted red fluorescent protein selectively inneurons: modeling mitochondriopathy in excitotoxicity and amyotrophic lateralsclerosis. Mol Neurodegener 2011; 6: 75.
122. Collins TJ, Berridge MJ, Lipp P, Bootman MD. Mitochondria are morphologicallyand functionally heterogeneous within cells. EMBO J 2002; 21: 1616-1627. (Pubitemid 34614618)
123. Verhoeven K, Claeys KG, Zuchner S, Schroder JM, Weis J, Ceuterick C et al. MFN2mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Brain 2006; 129(Pt 8): 2093-2102. (Pubitemid 44289074)
124. Nguyen D, Alavi MV, Kim KY, Kang T, Scott RT, Noh YH et al. A new vicious cycleinvolving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics.Cell Death Dis 2011; 2: e240.